Cargando…
The other side of the coin: Leveraging Epstein–Barr virus in research and therapy
Epstein-Barr virus is (EBV) a ubiquitous virus prevalent in 90% of the human population. Transmitted through infected saliva, EBV is the causative agent of infectious mononucleosis (IM) and is further implicated in malignancies of lymphoid and epithelial origins. In the past few decades, research ef...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108324/ https://www.ncbi.nlm.nih.gov/pubmed/27531881 http://dx.doi.org/10.1016/j.oraloncology.2016.07.010 |